Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cell Death and Disease | journal | 2.164 Q1 | 164 | 893 | 2228 | 42888 | 13727 | 2130 | 6.04 | 48.03 | |
2 | Oncogene | journal | 3.232 Q1 | 370 | 497 | 1689 | 24597 | 12127 | 1680 | 7.40 | 49.49 | |
3 | BMC Cancer | journal | 1.186 Q2 | 160 | 1247 | 3093 | 46764 | 10616 | 3089 | 3.26 | 37.50 | |
4 | Nature Reviews Cancer | journal | 21.287 Q1 | 505 | 132 | 345 | 7563 | 8499 | 203 | 22.27 | 57.30 | |
5 | European Journal of Cancer | journal | 3.410 Q1 | 245 | 348 | 1181 | 10254 | 7710 | 1011 | 6.21 | 29.47 | |
6 | Leukemia | journal | 3.966 Q1 | 219 | 311 | 1095 | 11860 | 7048 | 759 | 6.58 | 38.14 | |
7 | British Journal of Cancer | journal | 2.445 Q1 | 272 | 289 | 1270 | 10579 | 6998 | 1166 | 5.26 | 36.61 | |
8 | Molecular Cancer | journal | 4.581 Q1 | 196 | 158 | 409 | 12689 | 5911 | 375 | 15.19 | 80.31 | |
9 | Cancer Medicine | journal | 1.315 Q2 | 84 | 725 | 1247 | 28849 | 4677 | 1237 | 3.60 | 39.79 | |
10 | Journal of the National Cancer Institute | journal | 5.356 Q1 | 387 | 197 | 756 | 6628 | 4624 | 470 | 6.45 | 33.64 | |
11 | Neuro-Oncology | journal | 4.241 Q1 | 163 | 195 | 616 | 7053 | 4485 | 482 | 6.63 | 36.17 | |
12 | Journal of Experimental and Clinical Cancer Research | journal | 2.127 Q1 | 120 | 445 | 624 | 22862 | 4180 | 624 | 6.85 | 51.38 | |
13 | Journal of Hematology and Oncology | journal | 3.231 Q1 | 144 | 135 | 433 | 11212 | 4026 | 426 | 10.29 | 83.05 | |
14 | Journal for ImmunoTherapy of Cancer | journal | 4.194 Q1 | 117 | 336 | 336 | 13307 | 3108 | 310 | 9.55 | 39.60 | |
15 | Oral Oncology | journal | 1.735 Q1 | 137 | 317 | 798 | 9755 | 3046 | 652 | 3.57 | 30.77 | |
16 | Leukemia and Lymphoma | journal | 0.886 Q3 | 102 | 545 | 1369 | 14619 | 2242 | 797 | 1.69 | 26.82 | |
17 | Breast Cancer Research | journal | 2.407 Q1 | 175 | 154 | 404 | 7345 | 2137 | 394 | 4.57 | 47.69 | |
18 | Future Oncology | journal | 0.837 Q3 | 90 | 414 | 932 | 16241 | 1952 | 828 | 2.22 | 39.23 | |
19 | Endocrine-Related Cancer | journal | 1.545 Q2 | 146 | 102 | 430 | 7826 | 1874 | 391 | 4.22 | 76.73 | |
20 | Carcinogenesis | journal | 1.661 Q2 | 223 | 161 | 385 | 7247 | 1683 | 373 | 4.45 | 45.01 | |
21 | Cancer Cell International | journal | 1.055 Q2 | 80 | 336 | 412 | 14742 | 1619 | 412 | 3.98 | 43.88 | |
22 | Epigenomics | journal | 1.479 Q2 | 77 | 134 | 367 | 6873 | 1558 | 344 | 3.99 | 51.29 | |
23 | International Journal of Hyperthermia | journal | 0.704 Q3 | 98 | 181 | 473 | 7119 | 1363 | 443 | 2.73 | 39.33 | |
24 | ESMO Open | journal | 2.018 Q1 | 60 | 92 | 304 | 2841 | 1285 | 233 | 3.91 | 30.88 | |
25 | Signal Transduction and Targeted Therapy | journal | 3.755 Q1 | 117 | 62 | 89 | 5533 | 1190 | 85 | 13.85 | 89.24 | |
26 | Leukemia Research | journal | 0.780 Q3 | 96 | 147 | 568 | 4021 | 1189 | 507 | 2.07 | 27.35 | |
27 | Japanese Journal of Clinical Oncology | journal | 0.758 Q3 | 95 | 210 | 566 | 5497 | 1185 | 526 | 1.81 | 26.18 | |
28 | Cell Death Discovery | journal | 1.361 Q2 | 58 | 93 | 311 | 4260 | 1154 | 283 | 3.89 | 45.81 | |
29 | Journal of Oral Pathology and Medicine | journal | 0.809 Q3 | 95 | 131 | 424 | 3843 | 1132 | 399 | 2.69 | 29.34 | |
30 | Cancer Communications | journal | 1.423 Q2 | 79 | 81 | 225 | 3108 | 855 | 196 | 4.34 | 38.37 | |
31 | Prostate Cancer and Prostatic Diseases | journal | 1.830 Q1 | 78 | 80 | 201 | 2936 | 837 | 194 | 4.05 | 36.70 | |
32 | Cancer Gene Therapy | journal | 0.930 Q3 | 99 | 42 | 152 | 1296 | 670 | 147 | 3.98 | 30.86 | |
33 | Advances in Biological Regulation | journal | 2.040 Q1 | 69 | 42 | 130 | 3877 | 620 | 121 | 4.95 | 92.31 | |
34 | Hematological Oncology | journal | 0.728 Q3 | 54 | 119 | 307 | 3095 | 618 | 263 | 2.07 | 26.01 | |
35 | Molecular Therapy - Oncolytics | journal | 1.982 Q1 | 42 | 86 | 101 | 4730 | 558 | 100 | 4.05 | 55.00 | |
36 | ecancermedicalscience | journal | 0.572 Q3 | 47 | 115 | 297 | 4257 | 543 | 297 | 1.82 | 37.02 | |
37 | Molecular and Cellular Oncology | journal | 0.580 Q3 | 37 | 85 | 440 | 859 | 514 | 375 | 1.03 | 10.11 | |
38 | Infectious Agents and Cancer | journal | 0.955 Q3 | 47 | 47 | 157 | 1631 | 509 | 157 | 2.98 | 34.70 | |
39 | Experimental Hematology and Oncology | journal | 0.941 Q3 | 42 | 31 | 94 | 1280 | 305 | 92 | 3.66 | 41.29 | |
40 | npj Precision Oncology | journal | 36 | 33 | 28 | 1965 | 151 | 27 | 5.39 | 59.55 | ||
41 | Cancer Treatment and Research Communications | journal | 0.256 Q4 | 23 | 32 | 117 | 961 | 77 | 116 | 0.55 | 30.03 | |
42 | Cancer Reports | journal | 18 | 62 | 20 | 3690 | 7 | 19 | 0.35 | 59.52 | ||
43 | European Journal of Cancer, Supplement | journal | 0.383 Q4 | 29 | 0 | 1 | 0 | 3 | 1 | 0.00 | 0.00 | |
44 | FASEB BioAdvances | journal | 18 | 58 | 0 | 2798 | 0 | 0 | 0.00 | 48.24 | ||
45 | Molecular and Clinical Oncology | journal | 0.213 Q4 | 19 | 114 | 2 | 3370 | 0 | 2 | 0.00 | 29.56 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®